Table 1 Participant characteristics on demographic and clinical variables (n = 483).
From: Functional connectome differences in individuals with hallucinations across the psychosis continuum
SCZ-H (n = 99) | BD-H (n = 74) | BD (n = 42) | NC-H (n = 40) | HC (n = 228) | P value | |
---|---|---|---|---|---|---|
Age, mean (SD), years | 32.3 (10.9) | 46.2 (11.6) | 52.3 (11.9) | 43.1 (14.5) | 40.7 (14.6) | < 0.001* |
Gender, m/f | 67/32 | 37/37 | 23/19 | 10/30 | 121/107 | < 0.001* |
Handedness, R/L | 85/8 | 65/8 | 36/7 | 30/10 | 190/37 | 0.106 |
Motion, mm | ||||||
Relative mean displacement | 0.1 (0.04) | 0.1 (0.03) | 0.1 (0.03) | 0.08 (0.03) | 0.08 (0.03) | < 0.001* |
Diagnosis, No. (%) | ||||||
Schizophrenia | 59 (59.6) | |||||
Schizoaffective disorder | 17 (17.2) | |||||
Schizophreniform disorder | 1 (1.0) | |||||
Schizotypal personality | 1 (1.0) | |||||
Psychosis NOS | 20 (20.2) | |||||
Bipolar-I disorder | 74 (100) | 74 (100) | ||||
Medication, No. (%) | ||||||
Antipsychotics | 83 (83.8) | 39 (52.7) | 9 (21.4) | 0 (0.0) | 0 (0.0) | |
Lithium | 5 (5.1) | 42 (56.8) | 27 (64.3) | 0 (0.0) | 0 (0.0) | |
Anti-depressants | 22 (22.2) | 16 (21.6) | 10 (23.8) | 2 (5.0) | 3 (1.3) | |
Hallucinations lifetime, No. (%) | 99 (100) | 74 (100) | 0 (0.0) | 40 (100) | 0 (0.0) | |
Auditory | 80 (80.8) | 39 (52.7) | 0 (0.0) | 40 (100) | 0 (0.0) | < 0.001* |
Visual | 53 (53.5) | 51 (68.9) | 0 (0.0) | 33 (82.5) | 0 (0.0) | < 0.001* |
Hallucinations current, No. (%) | 57 (65.5) | 0 (0.0) | 0 (0.0) | 40 (100) | 0 (0.0) | |
Delusions lifetime, No. (%) | 72 (72.7) | 64 (86.5) | 0 (0.0) | 14 (35.0) | 1 (0.4) |